Last reviewed · How we verify
ALGINIC ACID
ALGINIC ACID is a alginic acid drug. It is currently in Phase 3 development.
Alginic acid forms a protective barrier over the stomach lining to prevent stomach acid from causing irritation.
Alginic acid is a naturally occurring polysaccharide derived from brown seaweed, used as a medication to treat conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers. It works by forming a protective barrier over the stomach lining, preventing stomach acid from coming into contact with the esophagus and causing irritation. Alginic acid is a small molecule drug classified under the alginic acid drug class, but its commercial status and approved indications are unclear. As a naturally occurring substance, it is not patented, and its safety profile is generally considered favorable. However, more information is needed to confirm its pharmacokinetic properties and clinical efficacy.
-
Baseline phase 3 → approval rate
+58.3pp
Industry-wide phase 3 drugs reach approval ~58.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2028–2030 | — |
| EMA | EU | 2029–2031 | +0.7 yr |
| MHRA | GB | 2029–2031 | +0.7 yr |
| Health Canada | CA | 2029–2032 | +0.9 yr |
| TGA | AU | 2029–2032 | +1.2 yr |
| PMDA | JP | 2029–2032 | +1.5 yr |
| NMPA | CN | 2030–2033 | +2.3 yr |
| MFDS | KR | 2029–2032 | +1.4 yr |
| CDSCO | IN | 2029–2033 | +1.8 yr |
| ANVISA | BR | 2030–2033 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | ALGINIC ACID |
|---|---|
| Drug class | alginic acid |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Imagine your stomach lining is like a delicate skin that can get irritated easily. Alginic acid works like a protective shield, covering the stomach lining and preventing stomach acid from coming into contact with it, which helps to reduce inflammation and discomfort.
Approved indications
Common side effects
- New Wound
- Infections
- Falls
- Maceration
- Wound Infection
- Pain
Key clinical trials
- Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia (NA)
- The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants (NA)
- Alginate vs Sucralfate for GERD Symptomatic Relief (PHASE2,PHASE3)
- Clinical Registry Collecting Real World Evidence on Wound Care Treatments
- Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU) (NA)
- Accuracy of Digital Mandibular Repositioning in Occlusal Reconstruction for Patients With Disc Displacement (NA)
- Efficacy of a Polyhexanide Biguanide-Based Gel in the Prevention of Biofilm Formation in Pressure Ulcers (EARLY_PHASE1)
- Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ALGINIC ACID CI brief — competitive landscape report
- ALGINIC ACID updates RSS · CI watch RSS
Frequently asked questions about ALGINIC ACID
What is ALGINIC ACID?
How does ALGINIC ACID work?
What drug class is ALGINIC ACID in?
What development phase is ALGINIC ACID in?
What are the side effects of ALGINIC ACID?
Related
- Drug class: All alginic acid drugs
- Therapeutic area: All drugs in Dermatology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing